AACR Cancer Disparities Progress Report 2024: Contents

A Snapshot of US Cancer Disparities in 2024 – CDPR24

A Snapshot of U.S. Cancer Disparities in 2024

Cancer health disparities caused by structural inequities are an enormous public health challenge in the United States.

The State of US Cancer Disparities in 2024 – CDPR24

The State of US Cancer Disparities in 2024

In recent decades, disparities in the burden of certain cancer types have declined among racial and ethnic minority populations. However, despite this progress, substantial differences in cancer burden remain, and constituents across the cancer care continuum are working together to understand and reduce cancer disparities.

Understanding and Addressing Drivers of Cancer Disparities – CDPR24

Understanding and Addressing Drivers of Cancer Disparities

Social drivers of health—which include socioeconomic status, social and built environments, and health care access—disparately and adversely affect racial and ethnic minority groups and medically underserved populations. Improving outcomes requires strategies at the population, institution, and community levels.

Understanding Cancer Development in the Context of Cancer Disparities – CDPR24

Understanding Cancer Development in the Context of Cancer Disparities

There are ancestry-related differences in cancer-driving cellular and molecular alterations. These biological differences among cancers in patients of different ancestries could provide novel targets for therapies and improve precision medicine.

Disparities in the Burden of Preventable Cancer Risk Factors – CDPR24

Disparities in the Burden of Preventable Cancer Risk Factors

Decades of systemic inequities and social injustices have led to adverse differences in drivers of health causing a disproportionately higher burden of cancer risk factors among US racial and ethnic minority groups and medically underserved populations.

Disparities in Cancer Screening for Early Detection – CDPR24

Disparities in Cancer Screening for Early Detection

Due to a multitude of systemic factors, racial and ethnic minority groups and medically underserved populations experience disparities in adherence to routine cancer screening and follow-up care. Evidence-based interventions are proving successful in reducing these screening disparities and improving outcomes.

Disparities in Clinical Research and Cancer Treatment – CDPR24

Disparities in Clinical Research and Cancer Treatment

Recent studies have shown that racial and ethnic disparities in outcomes for several types of cancer can be eliminated if every patient has equitable access to guideline-adherent treatments. Patient navigation and community engagement can eliminate the barriers to equitable treatment and reduce cancer disparities.

Disparities in Cancer Survivorship – CDPR24

Disparities in Cancer Survivorship

Medically underserved populations have more adverse side effects, poorer quality of life, and higher financial toxicity after a cancer diagnosis. Patient navigators, patient advocates, and culturally sensitive intervention/navigation programs are needed to improve the survivorship experience for these populations.

Overcoming Cancer Disparities Through Diversity in Cancer Training and Workforce – CDPR24

Overcoming Cancer Disparities Through Diversity in Cancer Training and Workforce

A diverse cancer care workforce enhances cultural competence in care delivery and builds public trust and participation in cancer research. To address cancer health disparities, it is imperative to invest in early-career researchers to increase diversity in cancer research and care.

Overcoming Cancer Disparities Through Science-based Public Policy – CDPR24

Overcoming Cancer Disparities Through Science-based Public Policy

Federal funding through agencies like NIH, FDA, CDC, and CMS; policies that expand early detection and cancer prevention; a new law to support increased diversity in clinical trials; and universal access to high-speed Internet to support telemedicine are all critical to eliminating cancer health disparities.

Conclusion – CDPR24

Conclusion

Continued transformative research and increased collaborations across the medical research community are key strategies for addressing cancer disparities.

AACR Call to Action – CDPR24

AACR Call to Action

To reduce cancer health disparities, AACR calls upon policy makers to improve collection of disaggregated data for minority groups; increase access and participation in clinical trials; enhance cancer prevention and screening efforts; ensure equitable patient care; and build a more diverse cancer research and care workforce.

AACR Initiatives Reducing Cancer Disparities and Promoting Health Equity – CDPR24

AACR Initiatives Reducing Cancer Disparities and Promoting Health Equity

As an organization whose core values include diversity, equity, and inclusion, AACR is deeply committed to achieving the bold vision of cancer health equity for all. Through a wide range of programs and initiatives, AACR fosters cancer health equity and advances its mission to prevent and cure all cancers—for all patients.

A Message from AACR – CDPR24

A Message from AACR

Clearly, we are in an era of extraordinary scientific progress against cancer. But along with these advances in cancer science and medicine, we must be equally committed to ensuring that no populations or communities are left behind

Executive Summary – CDPR24

Executive Summary

Thanks to research, we are making unprecedented progress against the many diseases we call cancer. However, these advances have not benefited everyone equally. It is imperative that everyone plays a role in eliminating the barriers to health equity, which is one of the most basic human rights.

Steering Committee – CDPR24

Steering Committee

Robert A. Winn, MD, FAACR, serves as the chair of the Steering Committee for the AACR Cancer Disparities Progress Report 2024.